TOP - Daily

Synribo (omacetaxine mepesuccinate) was recently approved by the FDA to treat adults with chronic myelogenous leukemia (CML) whose cancer has progressed after treatment with at least 2 tyrosine kinase inhibitors (TKIs).

Predicting a woman’s long-term risk for developing postmenopausal breast cancer was accomplished through the use of blood hormone testing.

For elderly female cancer survivors, achieving and maintaining a healthy body weight, staying physically active, and maintaining a healthy diet can improve survival after a cancer diagnosis.

Consuming green tea prior to undergoing prostatectomy reduced markers of inflammation in men with prostate cancer.

Individuals with lymphedema must learn how to cope with symptoms throughout their lifetimes.

Vegetables, including broccoli and brussel sprouts, were used to create a new compound that has been found to combat triple-negative breast cancer.

Annually, Medicare beneficiaries are overpaying by hundreds of dollars for their prescription benefits, an investigation by researchers reveals.

The US Administration on Aging forecasts that nearly 1 in 5 Americans will be 65 or older by 2030. Now, a new publication is intended to assist healthcare providers as they interact with this fastest growing sector of America’s population.

Recent study findings may clarify the reasons why exercise can significantly reduce the likelihood of secondary cancers in survivors.

A recent study shows that with the assistance of patient navigation services, breast cancer patients can reduce delays in the identification of the disease.